Do FIGO stage IA and small (≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery?

International Journal of Gynecological Cancer

Volumn 22, Issue 2, 2012, Pages 291-295

  Al Kalbani, Moza ^a   McVeigh, Gerard ^a   Nagar, Hans ^a   McCluggage, W Glenn ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Cervical adenocarcinoma; Early cervical cancer; Metastatic disease; Parametrial invasion

Indexed keywords

ADENOCARCINOMA; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CONSERVATIVE TREATMENT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS; OUTCOME ASSESSMENT; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SMALL CERVICAL ADENOCARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; HYSTERECTOMY; IRELAND; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84858223121     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182339fff     Document Type: Article

References (28)

1. UK Cancer research. Available at: http://www.cancerresearchuk.org. Accessed November 2010.
2. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 2007.
3. Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet. 2001;357:1490-1493. (Pubitemid 32488859)
4. McCluggage WG. Endocervical glandular lesions: controversial aspects and ancillary techniques. J Clin Pathol. 2003;56:164-173. (Pubitemid 36308029)
5. Ueda M, Ueki K, Kanemura M, et al. Conservative excisional laser conization for early invasive cervical cancer. Gynecol Oncol. 2004;95:231-234. (Pubitemid 39286303)
6. Yahata T, Nishino K, Kashima K, et al. Conservative treatment of stage IA1 adenocarcinoma of the uterine cervix with a long-term follow-up. Int J Gynecol Cancer. 2010;20:1063-1066.
7. Poynor EA, Marshall D, Sonoda Y, et al. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization. Gynecol Oncol. 2006;103:960-965. (Pubitemid 44821322)
8. Ceballos KM, Shaw D, Daya D. Microinvasive cervical adenocarcinoma (FIGO stage IA tumors): results of surgical staging and outcome analysis. Am J Surg Pathol. 2006;30:370-374. (Pubitemid 43740170)
9. Bisseling KC, Bekkers RL, Rome RM, et al. Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature. Gynecol Oncol. 2007;107:424-430. (Pubitemid 350160852)
10. Reynolds EA, Tierney K, Keeney G, et al. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type. Obstet Gynecol. 2010;116:1150-1157.
11. Hirai Y, Takeshima N, Tate S, et al. Early invasive cervical adenocarcinoma: its potential for nodal metastasis or recurrence. BJOG. 2003;110:241-245.
12. Kasamatsu T, Okada S, Tsuda H, et al. Early invasive adenocarcinoma of the uterine cervix: criteria for nonradical surgical treatment. Gynecol Oncol. 2002;85:327-332. (Pubitemid 34522994)
13. Balega J, Michael H, Hurteau J, et al. The risk of nodal metastasis in early adenocarcinoma of the uterine cervix. Int J Gynecol Cancer. 2004;14:104-109. (Pubitemid 38280631)
14. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. Int J Gynaecol Obstet. 2009;105:103-104.
15. Covens A, Rosen B, Murphy J, et al. How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol. 2002;84:145-149. (Pubitemid 34056481)
16. Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3-12. (Pubitemid 32062080)
17. Panici PB, Angioli R, Palaia I, et al. Tailoring the parametrectomy in stages IA2-IB1 cervical carcinoma: is it feasible and safe? Gynecol Oncol. 2005;96:792-798. (Pubitemid 40255503)
18. Magrina JF, Goodrich MA, Weaver AL, et al. Modified radical hysterectomy and mortality. Gynecol Oncol. 1995;59:277-282.
19. Forney JP. The effect of radical hysterectomy on bladder physiology. Am J Obstet Gynecol. 1980;138:374-382. (Pubitemid 11226065)
20. Frumovitz M, Sun CC, Schmeler KM, et al. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol. 2009;114:93-99.
21. Stegeman M, Louwen M, van der Velden J, et al. The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy. Gynecol Oncol. 2007;105:475-480. (Pubitemid 46591976)
22. Wright JD, Grigsby PW, Brooks R, et al. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer. 2007;110:1281-1286. (Pubitemid 47435599)
23. Smith HO, Qualls CR, Romero AA, et al. Is there a difference in survival for 1A1 and 1A2 adenocarcinoma of the uterine cervix? Gynecol Oncol. 2002;85:229-241. (Pubitemid 34522979)
24. Ostor AG, Duncan A, Quinn M, et al. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. Gynecol Oncol. 2000;79:207-210.
25. Ostor AG. Early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol. 2000;19:29-38. (Pubitemid 30010640)
26. Goldstein NS, Mani A. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ. Am J Clin Pathol. 1998;109:727-732. (Pubitemid 28247272)
27. Creasman WT. New gynecologic cancer staging. Gynecol Oncol. 1995;58:198-202.
28. Hirschowitz L, Ganesan R, Singh N. Dataset for the Histological Reporting of Cervical Neoplasia. London, UK: Royal College of Pathologists; 2008.